Showing results (61-70 of 110) with videos related to
Sort By:
Pageof 11
Frontiers in Immunology|May 18, 2026
MicroRNA-based integrated diagnosis and therapy for GBM: current status and advancesYe Chen, Huiyi Liu, Peipei Yuan, et al.Transplant Immunology|August 23, 2011
Arsenic trioxide is a novel agent for combination therapy to prolong heart allograft survival in allo-primed T cells transferred miceYingying Lin, Helong Dai, Jingjun Su, et al.Immunology Letters|April 11, 2017
Short-term clinical efficacy of percutaneous irreversible electroporation combined with allogeneic natural killer cell for treating metastatic pancreatic cancerMao Lin, Shuzhen Liang, Xiaohua Wang, et al.Immunological Investigations|October 9, 2009
Combined costimulation blockade inhibits accelerated rejection mediated by alloantigen-primed memory T cells in miceBaiyi Xie, Jibing Chen, Junjie Xia, et al.Cellular Immunology|June 18, 2013
Irinotecan combined with co-stimulatory molecule blockade prolongs survival of cardiac allografts in alloantigen-primed miceShifeng Zhang, Zhigang Chen, Ruwen Yang, et al.Cryobiology|July 13, 2013
Combination percutaneous cryotherapy and iodine-125 seed implantation for unresectable malignant thymoma: experience in 19 patientsZhikai Zhang, Binghui Wu, Lizhi Niu, et al.Journal of Cancer Research and Clinical Oncology|September 6, 2017
Percutaneous irreversible electroporation combined with allogeneic natural killer cell immunotherapy for patients with unresectable (stage III/IV) pancreatic cancer: a promising treatmentMao Lin, Shuzhen Liang, Xiaohua Wang, et al.Pancreas|August 1, 2013
Combination treatment with comprehensive cryoablation and immunotherapy in metastatic pancreatic cancerLizhi Niu, Jibing Chen, Lihua He, et al.Frontiers in Immunology|November 15, 2023
Subcutaneous device-free islet transplantationXudong Zhou, Zhiran Xu, Yanqiu You, et al.American Journal of Cancer Research|June 12, 2018
Cetuximab combined with natural killer cells therapy: an alternative to chemoradiotherapy for patients with advanced non-small cell lung cancer (NSCLC)Shuzhen Liang, Mao Lin, Lizhi Niu, et al.Pageof 11